Accelerate Your
Cell & Gene Therapy
Contract Development & Manufacturing
Accelerate Your
Cell & Gene Therapy
Contract Development & Manufacturing
At NecstGen, we enable the next generation of therapies by offering development support and GMP production of cell and gene therapies. Together, we challenge today’s possibilities and enable the unthinkable.
Are you bringing a Gene or Cell therapy to patients? We can help.
Solely dedicated to the field of Cell and Gene Therapy, we provide capacity, expertise, and services tailored accelerate the development of your therapy to the clinic and beyond. Our approach is characterised by open and transparent communication, fostering a culture of collaboration and knowledge sharing.
Cell Therapies
NecstGen offers services for Cell Therapy and Ex vivo Cell Therapy process and analytical development and manufacturing.
Viral Vectors
NecstGen provides a high-caliber process for Viral Vector manufacturing for your Gene Therapy.
Cleanroom Rental
NecstGen offers flexible GMP Cleanroom Rental at a state-of-the-art facility.
Consultancy & Support
At NecstGen, we support academic and industrial therapy developers in advancing Cell and Gene Therapies from concept to clinical reality. With our expertise on analytical and process development and manufacturing, we consult therapy developers allowing informed decision-making throughout all stages of therapy development .
“At NecstGen, we offer process development solutions, contract preclinical/ GMP manufacturing and cleanroom rental for Cell and Gene Therapies to clinicians, academic, small, medium, and large commercial organisations worldwide. We have a focused expert team and bespoke facility to offer you the support and capacity needed to deliver your therapy to patients.
We enable the next generation of therapies by translating research programs into health solutions for patients.“
News & Insights
TechTalk XL 2025: Cell & Gene Therapies
As part of Dutch Bio Science Week 2025, TechTalkXL brought together the Cell and Gene Therapy...
Webinar Improving Lentiviral Vector Yield with 2G UNic™ Technology
Improving Lentiviral Vector Yield with 2G UNic™ Technology Lentiviral vectors (LVs) are...
NecstGen and Astraveus Collaborate to Evaluate Benchtop Cell Factory™ Technology for Scalable CAR-T Manufacturing
NecstGen and Astraveus have joined forces to evaluate the Lakhesys™ Benchtop Cell Factory—a novel microfluidic platform designed to streamline and scale CAR-T manufacturing.
